Warner Pharmaceutical Factory (688799.SH) subsidiary's raw material drug Acetylcysteine has received approval notice for listing application.

The Zhifult Financial APP News, Warner Pharmaceutical Factory (688799.SH) issued an announcement. Recently, the company's wholly-owned subsidiary, Hunan Warner Dapharmaceutical Co., Ltd., received the "Approval Notice for the Application for Listing of Acetylcysteine Chemical Raw Materials" (Notification No. 2025YS00388) issued by the National Medical Products Administration, and it was also publicly displayed on the "Registration Information Publicity Platform for Active Pharmaceutical Ingredients, Pharmaceutical Excipients, and Pharmaceutical Packaging Materials" of the National Medical Products Administration Drug Evaluation Center (CDE).